Cytek Biosciences, Inc.
- Last sale
- Nov 5, 2026 · -8.50%
- Market cap
- $703.62M
- 130.78M shares
- Filings
- 466
Q3 2026+0.5% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−8.0% FY25 yoy
- $703.62M
- —
- 3.4×
- 2.2×
- -1.92%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 5, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $201,493,000 | reported | |
| FY 2024 | 2024-12-31 | $200,453,000 | reported | |
| FY 2023 | 2023-12-31 | $193,015,000 | reported | |
| FY 2022 | 2022-12-31 | $164,036,000 | reported | |
| FY 2021 | 2021-12-31 | $127,950,000 | reported | |
| FY 2020 | 2020-12-31 | $92,839,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $15.07M | $15.07M | — | 128.55M sh | +0.4% | — |
| FY2024 | — | $21.61M | $21.61M | — | 128.10M sh | −2.1% | 98.9% |
| FY2023 | — | $44.15M | $44.15M | — | 130.82M sh | −3.4% | 6974.9% |
| FY2022 | — | $0.00 | $0.00 | — | 135.43M sh | +1.0% | — |
| FY2021 | — | $0.00 | $0.00 | — | 134.08M sh | +329.2% | 0.0% |
Segments
LineFY2025ShareChange
United States$95.25M47%+2.9%
EMEA$55.88M28%−10.4%
APAC$41.08M20%+14.8%
China$20.50M10%—
Other$9.28M4.6%−4.6%
Total$201.49M
Laboratory analytical instruments
Cytek Biosciences, Inc. is the 10th largest of the 25 covered companies the SEC files under this code, by revenue. SIC 3826
CompanyRevenueGrowthNet marginMarket cap
TXG10x Genomics, Inc.$642.8M5.2%6.8%$7.5B
CTKBCytek Biosciences, Inc. (this company)$201.5M0.5%33.0%$703.6M
PACBPacific Biosciences of California, Inc.$160.0M3.9%341.5%$616.5MQTRXQuanterix Corp$138.9M1.1%77.1%$137.5MHBIOHarvard Bioscience Inc$86.6M8.1%65.5%$36.4MMASS908 Devices Inc.$56.2M17.7%34.7%$406.9MRPIDRapid Micro Biosystems, Inc.$33.6M19.7%140.3%$33.7MEYPTEyePoint, Inc.$31.4M27.5%739.4%$36.1MBNGOBionano Genomics, Inc.$28.5M7.4%92.6%$14.3MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR